Nucleophosmin 1 Mutations in Acute Myeloid Leukemia

被引:45
作者
Zarka, Jabra [1 ]
Short, Nicholas J. [1 ]
Kanagal-Shamanna, Rashmi [2 ]
Issa, Ghayas C. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
AML; nucleophosmin (NPM1); gene expression; targeted therapies; TUMOR-SUPPRESSOR PROTEIN; ACUTE MYELOGENOUS LEUKEMIA; MINIMAL RESIDUAL DISEASE; GENE-EXPRESSION PROFILE; NPM1; MUTATIONS; CLONAL HEMATOPOIESIS; MUTANT NUCLEOPHOSMIN; RIBOSOME BIOGENESIS; RETINOIC ACID; CYTOPLASMIC NUCLEOPHOSMIN;
D O I
10.3390/genes11060649
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein involved in ribosome biogenesis, the maintenance of genomic integrity and the regulation of the ARF-p53 tumor-suppressor pathway among multiple other functions. Mutations in the corresponding gene cause a cytoplasmic dislocation of the NPM1 protein. These mutations are unique to acute myeloid leukemia (AML), a disease characterized by clonal expansion, impaired differentiation and the proliferation of myeloid cells in the bone marrow. Despite our improved understanding ofNPM1mutations and their consequences, the underlying leukemia pathogenesis is still unclear. Recent studies that focused on dysregulated gene expression in AML with mutatedNPM1have shed more light into these mechanisms. In this article, we review the current evidence on normal functions of NPM1 and aberrant functioning in AML, and highlight investigational strategies targeting these mutations.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [41] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
    Gorello, P.
    Cazzaniga, G.
    Alberti, F.
    Dell'Oro, M. G.
    Gottardi, E.
    Specchia, G.
    Roti, G.
    Rosati, R.
    Martelli, M. F.
    Diverio, D.
    Lo Coco, F.
    Biondi, A.
    Saglio, G.
    Mecucci, C.
    Falini, B.
    LEUKEMIA, 2006, 20 (06) : 1103 - 1108
  • [42] Acute myeloid leukemia
    Doehner, K.
    Paschka, P.
    Doehner, H.
    INTERNIST, 2015, 56 (04): : 354 - 363
  • [43] Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia
    Guo-Rui Ruan
    Jin-Lan Li
    Ya-Zhen Qin
    Ling-Di Li
    Min Xie
    Yan Chang
    Yan Zhang
    Yan-Rong Liu
    Bin Jiang
    Shan-Shan Chen
    Xiao-Jun Huang
    Annals of Hematology, 2009, 88 : 159 - 166
  • [44] Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
    P Gorello
    G Cazzaniga
    F Alberti
    M G Dell'Oro
    E Gottardi
    G Specchia
    G Roti
    R Rosati
    M F Martelli
    D Diverio
    F Lo Coco
    A Biondi
    G Saglio
    C Mecucci
    B Falini
    Leukemia, 2006, 20 : 1103 - 1108
  • [45] Characteristics and Prognosis of "Acute Promyelocytic Leukemia-like" Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort
    Papadopoulou, Vasiliki
    Schiavini, Giulia
    Stalder, Gregoire
    Basset, Valentin
    Schoumans, Jacqueline
    Nabergoj, Mitja
    Schaller, Muriel
    BIOMEDICINES, 2024, 12 (10)
  • [46] Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
    Hirsch, Susanne
    Blaette, Tamara J.
    Grasedieck, Sarah
    Cocciardi, Sibylle
    Rouhi, Arefeh
    Jongen-Lavrencic, Mojca
    Paschka, Peter
    Kroenke, Jan
    Gaidzik, Verena I.
    Doehner, Hartmut
    Schlenk, Richard F.
    Kuchenbauer, Florian
    Doehner, Konstanze
    Dolnik, Anna
    Bullinger, Lars
    HAEMATOLOGICA, 2017, 102 (12) : 2039 - 2047
  • [47] Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia
    Chen, Yingyu
    Hu, Jianda
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [48] Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia
    Kovy, Petra
    Orfi, Zoltan
    Bors, Andras
    Kozma, Andras
    Gopcsa, Laszlo
    Dolgos, Janos
    Lovas, Nora
    Harasztdombi, Jozsef
    Lakatos, Viktor
    Kiraly, Agnes
    Mikala, Gabor
    Valyi-Nagy, Istvan
    Remenyi, Peter
    Andrikovics, Hajnalka
    PLOS ONE, 2021, 16 (06):
  • [49] Mutated NPM1 in patients with acute myeloid leukemia in remission and relapse
    Jain, Preetesh
    Kantarjian, Hagop
    Patel, Keyur
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Benjamini, Ohad
    Borthakur, Gautam
    Pemmaraju, Naveen
    Kadia, Tapan
    Daver, Naval
    Nazha, Aziz
    Luthra, Raja
    Pierce, Sherry
    Cortes, Jorge
    Ravandi, Farhad
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1337 - 1344
  • [50] PHF6 mutations in adult acute myeloid leukemia
    Van Vlierberghe, P.
    Patel, J.
    Abdel-Wahab, O.
    Lobry, C.
    Hedvat, C. V.
    Balbin, M.
    Nicolas, C.
    Payer, A. R.
    Fernandez, H. F.
    Tallman, M. S.
    Paietta, E.
    Melnick, A.
    Vandenberghe, P.
    Speleman, F.
    Aifantis, I.
    Cools, J.
    Levine, R.
    Ferrando, A.
    LEUKEMIA, 2011, 25 (01) : 130 - 134